Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Journal of Managed Care & Specialty Pharmacy
|
December 29, 2022
Inhaled treprostinil vs iloprost: Comparison of adherence, persistence, and health care resource utilization in patients with pulmonary arterial hypertension
Charles D Burger, Benjamin Wu, Peter Classi, et al.
Pulmonary Circulation
|
January 13, 2022
Reasons for refusing parenteral therapy: a qualitative study of patients with pulmonary arterial hypertension
Kellie Morland, Amresh Raina, Abigail Nails, et al.
Pulmonary Circulation
|
November 12, 2025
Real-World Comparison of Patients With PH-ILD Initiating Inhaled Treprostinil Versus Patients Who Remain Untreated
Steven J Cassady, Gautam V Ramani, Benjamin Wu, et al.
Respiratory Medicine
|
September 20, 2023
Burden of pulmonary hypertension due to chronic obstructive pulmonary disease: Analysis of exacerbations and healthcare resource utilization in the United States
James R Klinger, Benjamin Wu, Kellie Morland, et al.
International Journal of Technology Assessment in Health Care
|
December 7, 2016
IMPLICATION OF ALTERNATIVE MINIMAL CLINICALLY IMPORTANT DIFFERENCE THRESHOLD ESTIMATION METHODS ON TECHNOLOGY ASSESSMENT
Diana Brixner, Eli O Meltzer, Kellie Morland, et al.
Journal of Pain & Palliative Care Pharmacotherapy
|
October 15, 2019
Opioid-related respiratory and gastrointestinal adverse events in patients with acute postoperative pain: prevalence, predictors, and burden
Gary M Oderda, Anthony J Senagore, Kellie Morland, et al.
BMC Pulmonary Medicine
|
July 11, 2024
Burden of illness in patients with pulmonary hypertension due to interstitial lung disease: a real-world analysis
Gustavo Heresi, Bonnie Dean, Benjamin Wu, et al.
Chest
|
August 23, 2022
Considerations When Selecting Patient-Reported Outcome Measures for Assessment of Health-Related Quality of Life in Patients With Pulmonary Hypertension: A Narrative Review
Aaron Yarlas, Stephen C Mathai, Steven D Nathan, et al.
Lung
|
March 29, 2022
Identifying Patients with Group 3 Pulmonary Hypertension Associated with COPD or ILD Using an Administrative Claims Database
Gustavo A Heresi, Bonnie B Dean, Howard Castillo, et al.
Pulmonary Circulation
|
December 25, 2023
Real-world evidence to advance knowledge in pulmonary hypertension: Status, challenges, and opportunities. A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative's Real-world Evidence Working Group
Kellie Morland, Christian Gerges, Jean Elwing, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Journal of Managed Care & Specialty Pharmacy
|
December 29, 2022
Inhaled treprostinil vs iloprost: Comparison of adherence, persistence, and health care resource utilization in patients with pulmonary arterial hypertension
Charles D Burger, Benjamin Wu, Peter Classi, et al.
Pulmonary Circulation
|
January 13, 2022
Reasons for refusing parenteral therapy: a qualitative study of patients with pulmonary arterial hypertension
Kellie Morland, Amresh Raina, Abigail Nails, et al.
Pulmonary Circulation
|
November 12, 2025
Real-World Comparison of Patients With PH-ILD Initiating Inhaled Treprostinil Versus Patients Who Remain Untreated
Steven J Cassady, Gautam V Ramani, Benjamin Wu, et al.
Respiratory Medicine
|
September 20, 2023
Burden of pulmonary hypertension due to chronic obstructive pulmonary disease: Analysis of exacerbations and healthcare resource utilization in the United States
James R Klinger, Benjamin Wu, Kellie Morland, et al.
International Journal of Technology Assessment in Health Care
|
December 7, 2016
IMPLICATION OF ALTERNATIVE MINIMAL CLINICALLY IMPORTANT DIFFERENCE THRESHOLD ESTIMATION METHODS ON TECHNOLOGY ASSESSMENT
Diana Brixner, Eli O Meltzer, Kellie Morland, et al.
Journal of Pain & Palliative Care Pharmacotherapy
|
October 15, 2019
Opioid-related respiratory and gastrointestinal adverse events in patients with acute postoperative pain: prevalence, predictors, and burden
Gary M Oderda, Anthony J Senagore, Kellie Morland, et al.
BMC Pulmonary Medicine
|
July 11, 2024
Burden of illness in patients with pulmonary hypertension due to interstitial lung disease: a real-world analysis
Gustavo Heresi, Bonnie Dean, Benjamin Wu, et al.
Chest
|
August 23, 2022
Considerations When Selecting Patient-Reported Outcome Measures for Assessment of Health-Related Quality of Life in Patients With Pulmonary Hypertension: A Narrative Review
Aaron Yarlas, Stephen C Mathai, Steven D Nathan, et al.
Lung
|
March 29, 2022
Identifying Patients with Group 3 Pulmonary Hypertension Associated with COPD or ILD Using an Administrative Claims Database
Gustavo A Heresi, Bonnie B Dean, Howard Castillo, et al.
Pulmonary Circulation
|
December 25, 2023
Real-world evidence to advance knowledge in pulmonary hypertension: Status, challenges, and opportunities. A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative's Real-world Evidence Working Group
Kellie Morland, Christian Gerges, Jean Elwing, et al.
Page
of 1